Koyfin Home > Directory > Health Care > Edwards Lifesciences Corp > EBITDA / Interest Expenses

Edwards Lifesciences Corp EBITDA / Interest Expenses Chart (EW)

Edwards Lifesciences Corp annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Edwards Lifesciences Corp EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $487m a 73.65% increase of 359m year over year
  • Edwards Lifesciences Corp EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $69m a 5.10% increase of 4m year over year
  • Edwards Lifesciences Corp Annual EBITDA / Interest Expenses for 2019 was $66m a 41.35% increase of 27m from 2018
  • Edwards Lifesciences Corp Annual EBITDA / Interest Expenses for 2018 was $38m a -23.74% decrease of -9m from 2017
  • Edwards Lifesciences Corp Annual EBITDA / Interest Expenses for 2017 was $48m a 2.55% increase of 1m from 2016
Other Ratios Metrics:
  • Edwards Lifesciences Corp Total Debt / Capital for the quarter ending December 12, 2018 was $16m a -54.22% decrease of -9m year over year
  • Edwards Lifesciences Corp Other Liabilities for the quarter ending December 12, 2018 was $713m a -13.47% decrease of -96m year over year
  • Edwards Lifesciences Corp Total Debt / Equity for the quarter ending December 12, 2018 was $19m a -71.84% decrease of -14m year over year
View Chart On Koyfin

Quarterly EW EBITDA / Interest Expenses Data

09/2020$487m
12/2019$18m
12/2018$11m
09/2018$128m
06/2018$1,439m
12/2017$13m
09/2017$2,414m
06/2017$193m
03/2017$138m
12/2016$19m

Annual EW EBITDA / Interest Expenses Data

2019$66m
2018$38m
2017$48m
2016$46m
2015$41m
2014$33m
2013$55m
2012$108m
2011$116m
2010$142m